|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||9.40 - 10.12|
|52 Week Range||4.97 - 10.85|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Harvest Health & Recreation, Inc. (CSE: HARV, OTCQX: HRVSF) ("Harvest"), a vertically integrated and highly diversified cannabis company with a strong financial and growth profile, would become the largest multi-state operator (MSO) in the U.S. following closing of a definitive agreement signed on April 22, 2019 (the "Business Combination Agreement") to acquire (the "Transaction") Verano Holdings, LLC ("Verano"), as previously announced by press release dated March 11, 2019. Verano is one of the largest privately held multi-state, vertically integrated licensed operators of cannabis facilities with an extensive portfolio of premium branded products. Pursuant to the terms of the Business Combination Agreement, securityholders of Harvest and Verano will become securityholders in the combined company which will carry on the business of Harvest and Verano (the "Resulting Issuer").
Harvest Health & Recreation Inc (OTC: HRVSF ) reported fourth-quarter financial results Tuesday that include revenue growth of 135 percent on the year and 52 percent sequentially. What Happened The multistate ...
PHOENIX-- -- Total revenue for the three and 12 months ended December 31, 2018 increased 135% and 106%, respectively, from prior year. Total revenue for Q4 2018 increased 52% compared to Q3 2018. The Company continues to operate profitably; Adjusted EBITDA for the 12 months ended December 31, 2018 was $10.3 million . In 2018, successfully raised almost $300 million of funds, primarily consisting of: ...
"Thirty seconds for the market to open," a Toronto Stock Exchange representative said as the crowd started to clap, cheer and celebrate. It was the anniversary of the Evolve Marijuana ETF (TSX:SEED)(OTC:EVVLF) and they were celebrating being the best-performing equity ETF on the TSX in the last year.
NEW YORK , April 17, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the first quarter 2019 performance ...
Harvest Health & Recreation, Inc. will hold its Fourth Quarter 2018 earnings conference call on:
New assets and licenses in New Jersey, Pennsylvania, Maryland and Delaware extend Harvest’s unrivaled national U.S. presence allowing up to 213 facilities in 17 states and territories. Harvest to quickly bring leading brands/product lines, logistics and infrastructure from Falcon, CBx Enterprises and Verano to eastern retail and wholesale markets. Harvest Health & Recreation, Inc. (CSE: HARV, OTCQX: HRVSF) (“Harvest”), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., is pleased to announce it has entered into a binding, definitive agreement to acquire CannaPharmacy, Inc. (“CannaPharmacy”), subject to satisfaction of customary closing conditions, including receipt of regulatory approvals in the relevant states.
Cannabis stocks continued to trade in a holding pattern on Thursday, with investors awaiting the outcome of bipartisan legislation proposed in the House and Senate that would create protections for states that have legalized the substance for medical or recreational use.
Harvest Health & Recreation (HRVSF) has stated plans of becoming the largest cannabis company in the world. Investors might actually want to invest behind the company following the $850 million buyout of Verano considering the size of the U.S market relatively to the rest of the world.Massive U.S. Market Due to a cobbled together state-by-state approval of medical and/or recreational cannabis use, the stock market tends to forget that the U.S. market has the largest market size. This country might lack federal approval, but California alone is a larger market than the other countries, Canada and Uruguay, with both medical and recreational cannabis approved.The U.S. market in 2018 is estimated by Arcview Market Research to account for $11.0 billion out of the $12.9 billion global cannabis market. The U.S. market is set to control over 70% of the global market long into 2022 and beyond.The recent purchase of Verano by Harvest Health sets the stock up for one of the largest valuation in the domestic market with a market cap of around $4 billion.The company lacks the valuation of the large Canadian players on the major U.S. exchanges, but Harvest Health doesn’t lack for market opportunity.More ScaleThe Verano deal gets Harvest Health the scale needed to stick out from the crowded cannabis crowd. The company now competes with Curaleaf (CURLF) and Cresco Labs (CRLBF) for the most valuable U.S. cannabis firms.More importantly, Verano helps give Harvest the massive scale to attract investors and make a leap forward in their plan of becoming the largest cannabis company in the world. After the deal closes, Harvest will have licenses to operate up to 200 facilities in 16 states and territories (Puerto Rico), including 123 retail dispensaries. The company will have 70 dispensaries and 13 cultivation facilities operational by the end of 2019.Harvest Health already lists dispensaries in Arizona, California, Florida, Maryland and Pennsylvania with stores on the way in Massachusetts, Michigan, North Dakota and Ohio. One doesn’t need a lot of research to see access to even these limited states alone top the total market opportunity in Canada.Source: Harvest Health merger presentation As with a lot of the cannabis deals, the company provides sparse details on the acquired business other than being cash-flow positive operations with attractive cannabis licenses. For its part, Harvest Health has limited financials as well.Though, it doesn’t hurt to have a CCO with vast industry experience including the position of CEO of Pabst Blue Ribbon, a leading American beer company.TakeawayThe key investor takeaway is that Harvest Health & Recreation is on its way to becoming one of the most valuable global cannabis companies. The $850 million purchase of Verano helps accelerate that path, but the real key is the focus on domestic expansion and acquisitions where the market is quickly developing into the most valuable market in the world by far.The stock has rallied from below $6 right before the merger announcement on March 11 to over $10 now. The stock is up over 70% in the matter of a month suggesting investors might want to let the stock cool off before looking for a long-term investment. Ultimately though, investors should favor backing a large company in the largest cannabis market trading at a fraction of a Canadian stocks needing massive international expansion in order to justify their stock prices.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here. Disclosure: The author has no position in HRVSF. The information contained herein is for informational purposes only. More recent articles from Smarter Analyst: * What's in Store for Alibaba (BABA) Stock Ahead of Earnings * China Worries Aside, Top Analyst Bullish on Starbucks (SBUX) Stock Ahead of Earnings * Has Boeing (BA) Stock Hit Bottom? Looking for the Silver Lining * Facebook (FB) Stock: The Turnaround Is Real
Harvest Health & Recreation, Inc. (CSE: HARV, OTCQX: HRVSF) (“Harvest”), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., today announced that it has entered into an engagement agreement for a brokered private sale of up to 500,000 convertible debentures (the “Debentures”) of Harvest, at a price of US$1,000 per Debenture, for gross proceeds of US$500 million (the “Offering”). The Offering is intended to be closed in five tranches of 100,000 Debentures per tranche, over a period of not more than 18 months. The net proceeds of the Offering will be used by Harvest for working capital and general corporate purposes. The first tranche of the Offering is expected to close on May 1, 2019 and subsequent tranches are issuable at the option of Harvest, subject to certain conditions. Concurrently with the engagement agreement, Harvest also entered into an agreement with a lead investor (the “Lead Investor”) to subscribe for the full amount of the Offering (the “Agreement”).
Harvest Health & Recreation, Inc. (CSE: HARV, OTCQX: HRVSF) (“Harvest”), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., announced the opening of its first California cannabis dispensary in Napa, which is the city’s first medical cannabis location to open its doors to patients. Pending finalization of an acquisition of Falcon International Corp.—the state’s leading operator in logistics serving more than 80 percent of dispensaries—Harvest will hold California licenses California for state-wide distribution, cultivation and manufacturing.
HENDERSON, NV / ACCESSWIRE / April 2, 2019 / According to a new report from Zion Market Research, the global cannabis beverages market was at approximately USD 1.6 billion in 2018 and is expected to generate ...
POINT ROBERTS, Wash. and DELTA, British Columbia, March 26, 2019 -- Investorideas.com, a leading investor news resource covering hemp and cannabis stocks continues with our two.
CORAL GABLES, FL / ACCESSWIRE / March 25, 2019 / The marijuana stock market has endured a whirlwind of volatility over the course of the last few years but in the first few months of 2019, companies in the cannabis sector have managed to stay strong through bearish periods of trading. It seems as though a significant portion of the changes taking place in the marijuana industry is directly connected to the recent push from the public who are insisting that lawmakers pass positive cannabis legislation. Whereas in the past cannabis was largely condemned, nowadays, consumers are well-versed in the potential health benefits of cannabis products, and the general feeling towards the cannabis sector is shifting in a positive direction.
Last week, the bill that will allow the good people of New Jersey to legally buy and consume adult-use cannabis, cleared the Assembly Appropriations Committee. Investors who have been following legalization developments in New Jersey are likely encouraged by this recent move.
Cochran will discuss how cannabis businesses can tap the beverage market boom. LAS VEGAS and CLEVELAND , March 20, 2019 /PRNewswire/ -- John Cochran, Chief Operating Officer of Harvest Health & Recreation ...
HENDERSON, NV / ACCESSWIRE / March 19, 2019 / On Tuesday, New Jersey lawmakers announced that they have reached a deal on cannabis legalization after months of talks and negotiations. The details are expected ...
CORAL GABLES, FL / ACCESSWIRE / March 18, 2019 / The marijuana stock market has been something of a media phenomenon the last few years as the cannabis industry has evolved following the advent of significant legislation in support of legalization. Doctors and experts in the medical community are now advocating that patients consider medicinal cannabis as a form of alternative treatment for pain relief and symptomatic alleviations related to inflammatory diseases. If companies in the cannabis sector continue to innovate products for consumers and shift the tides that previously condemned the industry, this could generate investor excitement.
CORAL GABLES, FL / ACCESSWIRE / March 15, 2019 / The marijuana stock market has shown exciting promise during the month of March, as we've seen cannabis companies make their way back to their pre-pullback levels. The first few weeks of 2019 served as a reminder that marijuana stocks can have high volatility at times, especially after we saw a decline in the prices of several major cannabis stocks. Given the nascency of the cannabis sector, investors looking for potential opportunities should continue to pay attention to companies regardless of their volatility ParcelPal Technology Inc (PTNYF) (PKG), Charlotte's Web Holdings Inc (OTCQX:CWBHF), HEXO Corp (TSX:HEXO), and Harvest Health & Recreation Inc (HRVSF) represent 4 marijuana stocks looking to close out a strong week.
Harvest Health & Recreation, Inc. (the "Corporation" or "Harvest") (CSE: HARV, OTCQX: HRVSF), a vertically integrated public cannabis company announces grants of stock options pursuant to the stock option plan of the Corporation, whereby the Corporation has granted a total of 12,350,250 stock options to certain officers, directors, employees or consultants of the Corporation. Each stock option, granted on March 13, 2019, will entitle the holder thereof to purchase one common share of the Corporation at a price of CND $10.20 per share (subject to adjustment in accordance with the stock option plan of the Corporation) until March 13, 2029.
When it comes to legal weed, Canada certainly has the first-mover advantage … but I'm seeing more opportunity here in the United States for marijuana stocks. Having passed full legalization last fall, Canada is projected to be a $5.9 billion market for legal cannabis by 2022. That's about where the U.S. market was in 2015. And that was when only four states, plus D.C., had full legalization.Now we're up to 11 states when you include Alaska. (And many more allow medicinal use.) By 2017, the U.S. legal marijuana market had exploded 57.4% to reach $8.5 billion.To put that figure in its proper perspective, the $8.5 billion spent buying legal pot was more money than Americans spent on ice cream!InvestorPlace - Stock Market News, Stock Advice & Trading TipsBy 2018, we were at $10.4 billion. And according to Arcview Market Research and BDS Analytics, we'll easily keep up that pace through 2022 -- when U.S. spending will reach $22.2 billion. * 7 Disruptive Tech ETFs to Buy That'll be nearly four times the size of Canada's marijuana market. Marijuana Legalization Is on the MoveThere's a huge potential catalyst on the horizon for marijuana stocks, in the form of the STATES Act.STATES is short for Strengthening the Tenth Amendment Through Entrusting States. The Act is a bipartisan bill put together by Senators Cory Gardner (R-CO) and Elizabeth Warren (D-MA). The legislation was introduced last June. If passed, it would amend the Controlled Substances Act.This is big because the federal prohibition would be eliminated in states that legalize marijuana. As long as residents follow their state's laws on marijuana, the federal government would not be able to intervene.The odds of the bill getting passed this year are very high. It would make it even easier for more states to legalize marijuana. More importantly, it would be the first major step to federal legalization … and that's when the opportunity opens up all the way. 'Merger Fever' Starting to SpreadHarvest Health & Recreation (OTCMKTS:HRVSF) has picked up on the trend of already increasing sales and the potential for explosive growth. The Arizona-based cannabis grower and retailer went public on the Canadian Securities Exchange last November -- and is also trading on the OTC Markets in the United States under the symbol HRVSF.From its home base in Phoenix, Harvest Health has already spread to eight other states (within just six years). And on Monday, it announced a merger with Verano Holdings, in which the combined company will own licenses for up to 200 facilities across 16 states.The buyout comes with a steep price tag: $850 million (U.S. dollars). That's the biggest marijuana merger since the $835 million deal between iAnthus Capital (OTCMKTS:ITHUF) and MPX Bioceuticals in October.Taken together, that's $1.5 billion in just two corporate mergers. You think they don't see opportunity?Harvest may have inked the bigger deal, but I actually prefer iAnthus as an investment.Ianthus owns and operates cannabis cultivators, processors, and dispensaries in the United States. Now that it has merged with MPX, it has operations in 11 states, more than 60 retail locations, and over 500,000 square feet of cultivation and processing space.I saw huge upside potential in iAnthus going back to last year. It's up nearly 30% just in 2019 alone, and management said this will be a "transformative year" for the company. I couldn't agree more. As the integration of iAnthus and MPX progresses, it will lead to impressive financials as the U.S. opportunity continues to grow.Based on 2020 revenue expectations of $336 million, iAnthus trades with an Enterprise Value/Revenue ratio of 1.15. This is the lowest of all the major U.S. marijuana stocks. Even more impressive is that iAnthus is expected to be one of the first companies in the industry to turn a meaningful profit.Based on 2020 earnings estimates, ITHUF stock trades with a price-earnings (P/E) ratio of 17.9. With the kind of growth prospects I've outlined here, that makes iAnthus a phenomenal bargain.Matthew McCall is the founder and president of Penn Financial Group, an investment advisory firm, as well as the editor of Investment Opportunities and Early Stage Investor. He has dedicated his career to getting investors into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA), +1,044% in Tesla (TSLA), +611% in Liquefied Natural Gas Limited (LNGLY), +324% in Bitcoin Services (BTSC), just to name a few. If you're interested in making triple-digit gains from the world's biggest investment trends BEFORE anyone else, click here to learn more about Matt McCall and his investments strategy today. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 of the Best Stocks to Buy Under $10 * 7 Retail Stocks Winning in 2019 and Beyond * The 10 Best Stocks to Buy for the Bull Market's Anniversary Compare Brokers The post As U.S. Market Heats Up, These Marijuana Stocks are Cashing In appeared first on InvestorPlace.